Enhanced Myogenic Constriction in the SHR Preglomerular Vessels Is Mediated by Thromboxane A2 Synthesis

被引:2
|
作者
Nademi, Samera [1 ]
Lu, Chao [2 ]
Dickhout, Jeffrey G. [1 ,2 ]
机构
[1] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada
[2] St Josephs Healthcare Hamilton, Hamilton, ON, Canada
基金
加拿大健康研究院;
关键词
myogenic constriction; renal autoregulation; preglomerular arteries; hypertension; prostaglandin; thromboxane A2; nitric oxide; endothelium; MESENTERIC RESISTANCE ARTERIES; NITRIC-OXIDE; RENAL DAMAGE; CEREBRAL-ARTERIES; PLASMA ENDOTHELIN; BLOOD-FLOW; PRESSURE; HYPERTENSION; SENSITIVITY; RESPONSES;
D O I
10.3389/fphys.2020.00853
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background Spontaneously Hypertensive Rats (SHR) have chronically elevated blood pressures at 30 weeks of age (systolic: 191.0 +/- 1.0, diastolic: 128.8 +/- 0.9). However, despite this chronic malignant hypertension, SHR kidneys remain relatively free of pathology due to having an augmented myogenic constriction (MC). We hypothesized that the enhanced MC in the SHR preglomerular vessels was due to increased prostaglandin and decreased nitric oxide (NO) synthesis, providing renal protection. Methods SHR and Wistar Kyoto (WKY) arcuate and mesenteric arteries were treated with indomethacin (prostaglandin synthesis inhibitor), N omega-nitro-L-arginine (L-NNA, NO synthase inhibitor), and nifedipine (L-type calcium channel blocker); and MC was measured in these vessels. The role of endothelium in MC was examined by removing endothelium from WKY and SHR preglomerular and mesenteric arteries using human hair, and measuring MC. We also studied the source of prostaglandin in the SHR by treating endothelium-removed arcuate arteries with indomethacin and furegrelate (thromboxane synthase inhibitor). Results MC was enhanced in the SHR preglomerular vessels but not the mesenteric arteries. Indomethacin and LNNA removed the enhanced MC in the SHR. Nifedipine also inhibited MC in both WKY and SHR arcuate and mesenteric arteries. Removing endothelium did not change MC in either arcuate or mesenteric arteries of WKY and SHR rats; and did not remove the augmented MC in the SHR arcuate arteries. Indomethacin and furegrelate decreased MC in endothelium-removed SHR arcuate arteries and obliterated the enhanced MC in the SHR. Conclusion The enhanced MC in the SHR arcuate arteries was due to thromboxane A2 synthesis from the tunica media and/or adventitia layers. MC was not dependent on endothelium, but was dependent on L-type calcium channels. Nevertheless, SHR arcuate arteries displayed differential intracellular calcium signaling compared to the WKYs.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Thromboxane A2 contributes to the enhanced tubuloglomerular feedback activity in young SHR
    Brännström, K
    Arendshorst, WJ
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 276 (05) : F758 - F766
  • [2] HYPOXIA AND THROMBOXANE (TX) A2 SYNTHESIS INHIBITORS CAUSE CORONARY CONSTRICTION IN RAT HEARTS
    KARMAZYN, M
    HORROBIN, DF
    CLINICAL RESEARCH, 1978, 26 (04): : A601 - A601
  • [3] Endothelin and prostaglandin H2/thromboxane A2 enhance myogenic constriction in hypertension by increasing Ca2+ sensitivity of arteriolar smooth muscle
    Ungvari, Z
    Koller, A
    HYPERTENSION, 2000, 36 (05) : 856 - 861
  • [4] THROMBOXANE A2 MEDIATES VENOUS CONSTRICTION DURING HYPOXIA IN LUNGS OF NEWBORN LAMBS
    CHEN, P
    RAJ, JU
    FEDERATION PROCEEDINGS, 1987, 46 (04) : 1110 - 1110
  • [5] Flow-induced constriction in arterioles of hyperhomocysteinemic rats is due to impaired nitric oxide and enhanced thromboxane A2 mediation
    Bagi, Z
    Ungvari, Z
    Szollár, L
    Koller, A
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (02) : 233 - 237
  • [6] Stimulation of thromboxane A2 receptor induced the constriction and remodeling of the ductus arteriosus in the rat
    Yokota, Tomohiro
    Aida, Takashi
    Shiraishi, Ryosuke
    Ichikawa, Yasuhiro
    Fujita, Takayuki
    Yokoyama, Utako
    FASEB JOURNAL, 2012, 26
  • [7] The role of angiogenesis of thromboxane A2 synthesis protein
    Chu, Pao-Hsien
    VIRCHOWS ARCHIV, 2007, 451 (02) : 272 - 272
  • [8] Blood Pressure (BP) decreases with the Thromboxane A2 receptor antagonism in male SHR.
    Acosta, MC
    Fortepiani, LA
    Zhang, HM
    Sirinvastava, K
    Reckelhoff, J
    FASEB JOURNAL, 2002, 16 (05): : A793 - A793
  • [9] THROMBOXANE A2 MEDIATED BRONCHOCONSTRICTION IN THE ANESTHETIZED GUINEA-PIG
    GREENBERG, R
    ANTONACCIO, MJ
    STEINBACHER, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 80 (01) : 19 - 27
  • [10] Synthesis and thromboxane A2 antagonistic activity of indane derivatives
    Shinozaki, K
    Sato, H
    Iwakuma, T
    Sato, R
    Kurimoto, T
    Yoshida, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) : 401 - 406